BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31077012)

  • 21. Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.
    Uddin S; Bu R; Ahmed M; Abubaker J; Al-Dayel F; Bavi P; Al-Kuraya KS
    Mol Cancer; 2009 Sep; 8():74. PubMed ID: 19765303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression.
    Zhu J; Lu X; Hua KQ; Sun H; Yu YH; Feng YJ
    Arch Gynecol Obstet; 2012 Sep; 286(3):729-37. PubMed ID: 22569715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptin promotes proliferation and metastasis of human gallbladder cancer through OB-Rb leptin receptor.
    Zou H; Liu Y; Wei D; Wang T; Wang K; Huang S; Liu L; Li Y; Ge J; Li X; Zhu H; Wang L; Zhao S; Zhang X; Wang L
    Int J Oncol; 2016 Jul; 49(1):197-206. PubMed ID: 27211817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells.
    Li S; Hu R; Wang C; Guo F; Li X; Wang S
    Mol Med Rep; 2014 Jun; 9(6):2393-9. PubMed ID: 24715036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
    Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
    Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
    Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of semaphorin 4D expression and cell proliferation of ovarian cancer by ERalpha and ERbeta.
    Liu Y; Hou Y; Ma L; Sun C; Pan J; Yang Y; Zhou H; Zhang J
    Braz J Med Biol Res; 2017 Feb; 50(3):e6057. PubMed ID: 28225892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.
    Li J; Zhuang Q; Lan X; Zeng G; Jiang X; Huang Z
    IUBMB Life; 2013 Dec; 65(12):1017-25. PubMed ID: 24376209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
    Kato S; Abarzua-Catalan L; Trigo C; Delpiano A; Sanhueza C; García K; Ibañez C; Hormazábal K; Diaz D; Brañes J; Castellón E; Bravo E; Owen G; Cuello MA
    Oncotarget; 2015 Aug; 6(25):21100-19. PubMed ID: 26053184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
    Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
    Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer.
    Ma H; Tian T; Liang S; Liu X; Shen H; Xia M; Liu X; Zhang W; Wang L; Chen S; Yu L
    Oncotarget; 2016 Mar; 7(9):10594-605. PubMed ID: 26871282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of estrogen receptor beta in ovarian carcinogenesis.
    Bardin A; Hoffmann P; Boulle N; Katsaros D; Vignon F; Pujol P; Lazennec G
    Cancer Res; 2004 Aug; 64(16):5861-9. PubMed ID: 15313930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of estrogen on leptin and expression of leptin receptor transcripts in prepubertal dairy heifers.
    Thorn SR; Meyer MJ; Van Amburgh ME; Boisclair YR
    J Dairy Sci; 2007 Aug; 90(8):3742-50. PubMed ID: 17638985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail.
    Ding JX; Feng YJ; Yao LQ; Yu M; Jin HY; Yin LH
    Gynecol Oncol; 2006 Nov; 103(2):623-30. PubMed ID: 16806441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
    Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
    Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients.
    Czogalla B; Kahaly M; Mayr D; Schmoeckel E; Niesler B; Kolben T; Burges A; Mahner S; Jeschke U; Trillsch F
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol increases cell growth in human astrocytoma cell lines through ERα activation and its interaction with SRC-1 and SRC-3 coactivators.
    González-Arenas A; Hansberg-Pastor V; Hernández-Hernández OT; González-García TK; Henderson-Villalpando J; Lemus-Hernández D; Cruz-Barrios A; Rivas-Suárez M; Camacho-Arroyo I
    Biochim Biophys Acta; 2012 Feb; 1823(2):379-86. PubMed ID: 22142990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.